Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12160-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12160-1-AP, RRID:AB_10598009
- Product name
- PAR2 antibody
- Antibody type
- Polyclonal
- Description
- PAR2 antibody (Cat. #12160-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Heat acclimation defense against exertional heat stroke by improving the function of preoptic TRPV1 neurons.
PAR2 promotes malignancy in lung adenocarcinoma.
Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose.
Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury.
Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Choroid plexus mast cells drive tumor-associated hydrocephalus.
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy.
Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
Toward drugs for protease-activated receptor 2 (PAR2).
Li J, Zhou Z, Wu Y, Zhao J, Duan H, Peng Y, Wang X, Fan Z, Yin L, Li M, Liu F, Yang Y, Du L, Li J, Zhong H, Hou W, Zhang F, Ma H, Zhang X
Theranostics 2025;15(4):1376-1398
Theranostics 2025;15(4):1376-1398
PAR2 promotes malignancy in lung adenocarcinoma.
Wang B, Wu MD, Lan YJ, Jia CY, Zhao H, Yang KP, Liu HN, Sun SZ, Tao RC, Lu XD, Zhang ZF
American journal of translational research 2024;16(12):7416-7426
American journal of translational research 2024;16(12):7416-7426
Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose.
Wang H, She X, Xu Q, Zhou X, Tang Q, Wei H, Huang T, Liang F
Oral diseases 2024 Oct;30(7):4195-4208
Oral diseases 2024 Oct;30(7):4195-4208
Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury.
Sui X, Xie T, Xu Y, Zhang A, Zhang Y, Gu F, Li L, Xu Z, Chen J
Mediators of inflammation 2023;2023:5007488
Mediators of inflammation 2023;2023:5007488
Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Zhang K, Liu C, Hu C, Lin P, Qi Q, Jia H, Tang J, Yu X
Heliyon 2023 Jun;9(6):e16870
Heliyon 2023 Jun;9(6):e16870
Choroid plexus mast cells drive tumor-associated hydrocephalus.
Li Y, Di C, Song S, Zhang Y, Lu Y, Liao J, Lei B, Zhong J, Guo K, Zhang N, Su S
Cell 2023 Dec 21;186(26):5719-5738.e28
Cell 2023 Dec 21;186(26):5719-5738.e28
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
Liu C, Jiang S, Xie H, Jia H, Li R, Zhang K, Wang N, Lin P, Yu X
Medical oncology (Northwood, London, England) 2022 May 16;39(5):94
Medical oncology (Northwood, London, England) 2022 May 16;39(5):94
Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy.
Kim Y, Lee Y, Heo G, Jeong S, Park S, Yoo JW, Jung Y, Im E
Cells 2022 Mar 3;11(5)
Cells 2022 Mar 3;11(5)
Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
Du C, Zhang T, Xiao X, Shi Y, Duan H, Ren Y
The Biochemical journal 2017 Aug 2;474(16):2733-2747
The Biochemical journal 2017 Aug 2;474(16):2733-2747
Toward drugs for protease-activated receptor 2 (PAR2).
Yau MK, Liu L, Fairlie DP
Journal of medicinal chemistry 2013 Oct 10;56(19):7477-97
Journal of medicinal chemistry 2013 Oct 10;56(19):7477-97
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PAR2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PAR2. This antibody recognizes human,mouse,rat antigen. The PAR2 antibody has been validated for the following applications: ELISA, WB analysis.
